Ultrasonographic-guided pervaginal cul-de-sac cytology in the follow-up of ovarian carcinoma. 2007

Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
Department of Obstetrics and Gynecology, Tampere University Hospital, Tampere, Finland. maarit.vuento@pshp.fi

The aim of this study was to compare, prospectively, traditional pervaginal cul-de-sac aspiration cytology with an ultrasonographic-guided aspirate in the detection of residual or recurrent ovarian carcinoma. METHODS Fifty-one patients with ovarian carcinoma were monitored during chemotherapy (21 patients) or follow-up (30 patients) after first-line treatment. All patients underwent both traditional blind pervaginal cul-de-sac aspiration cytology and an ultrasonographic-guided pervaginal aspirate. The samples were classified as class 0 or insufficient when no mesothelial cells were detected in the aspirate. The results of cytological classification of the aspirates were compared with each other according to sampling order. RESULTS Samples were classified as class 0 in 56% when the traditional cul-de-sac aspiration was taken first, and in 73% when ultrasonographic-guided aspiration was taken first (p = 0.249, Fisher's exact test). The number of class 0 samples was smaller among those taken second than among those taken first (22 (44%) vs. 33 (65%), p = 0.046). Four recurrences were detected during the mean follow-up of six months (range 2-11 months) in 30 patients who were followed-up after the first-line treatment. In one case, a positive cul-de-sac cytology was the first and only early indication of recurrence. CONCLUSIONS The use of ultrasonography did not improve the accuracy of the cul-de-sac aspiration. The greater amount of fluid in the cul-de-sac during the second sampling might contribute to achieving a better result.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009364 Neoplasm Recurrence, Local The local recurrence of a neoplasm following treatment. It arises from microscopic cells of the original neoplasm that have escaped therapeutic intervention and later become clinically visible at the original site. Local Neoplasm Recurrence,Local Neoplasm Recurrences,Locoregional Neoplasm Recurrence,Neoplasm Recurrence, Locoregional,Neoplasm Recurrences, Local,Recurrence, Local Neoplasm,Recurrence, Locoregional Neoplasm,Recurrences, Local Neoplasm,Locoregional Neoplasm Recurrences,Neoplasm Recurrences, Locoregional,Recurrences, Locoregional Neoplasm
D009367 Neoplasm Staging Methods which attempt to express in replicable terms the extent of the neoplasm in the patient. Cancer Staging,Staging, Neoplasm,Tumor Staging,TNM Classification,TNM Staging,TNM Staging System,Classification, TNM,Classifications, TNM,Staging System, TNM,Staging Systems, TNM,Staging, Cancer,Staging, TNM,Staging, Tumor,System, TNM Staging,Systems, TNM Staging,TNM Classifications,TNM Staging Systems
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
September 1986, Gynecologic oncology,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
August 1980, Gynecologic oncology,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
January 1995, Acta oncologica (Stockholm, Sweden),
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
November 1985, The Journal of reproductive medicine,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
December 1966, Surgery,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
November 1987, Nihon Sanka Fujinka Gakkai zasshi,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
June 1967, The Journal of obstetrics and gynaecology of the British Commonwealth,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
February 1992, American journal of obstetrics and gynecology,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
January 1975, Acta cytologica,
Maarit Vuento, and Tuula Salmi, and Pekka Klemi, and Seija Grénman
October 1966, Archives of ophthalmology (Chicago, Ill. : 1960),
Copied contents to your clipboard!